Results of a clinical trial show that a new vaccine against tuberculosis is effective in preventing tuberculosis in people with HIV infection. Scientists found that MV immunization reduced the rate of definite tuberculosis by 39 percent among 2,000 HIV-infected patients in Tanzania.